日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation

色瑞替尼对胆管癌的治疗意义(ALK 表达和突变除外)

Kyaw Zwar Myint, Brinda Balasubramanian, Simran Venkatraman, Suchada Phimsen, Supisara Sripramote, Jeranan Jantra, Chaiwat Choeiphuk, Somkit Mingphruedhi, Paramin Muangkaew, Narongsak Rungsakulkij, Pongsatorn Tangtawee, Wikran Suragul, Watoo Vassanasiri Farquharson, Kanokpan Wongprasert, Somchai Chu

Upregulated LAMA3 modulates proliferation, adhesion, migration and epithelial‑to‑mesenchymal transition of cholangiocarcinoma cells

上调的 LAMA3 调节胆管癌细胞的增殖、粘附、迁移和上皮-间质转化

Kittiya Islam, Brinda Balasubramanian, Simran Venkatraman, Parichut Thummarati, Janpen Tunganuntarat, Nut Phueakphud, Phongthon Kanjanasirirat, Tanawadee Khumpanied, Pornparn Kongpracha, Yingpinyapat Kittirat, Rutaiwan Tohtong, Tavan Janvilisri, Patompon Wongtrakoongate, Suparerk Borwornpinyo, Nisan

Preclinical evidence for anaplastic lymphoma kinase inhibitors as novel therapeutic treatments for cholangiocarcinoma

间变性淋巴瘤激酶抑制剂作为胆管癌新型治疗方法的临床前证据

Kyaw Zwar Myint,Mireia Sueca-Comes,Pamela Collier,Brinda Balasubramanian,Simran Venkatraman,John Gordan,Abed M Zaitoun,Abhik Mukherjee,Arvind Arora,Noppadol Larbcharoensub,Chinnawut Suriyonplengsaeng,Kanokpan Wongprasert,Tavan Janvilisri,Dhanny Gomez,Anna M Grabowska,Rutaiwan Tohtong,David O Bates,Kiren Yacqub-Usman

Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma

使用 PD173074 靶向 FGFR 作为胆管癌的新型治疗策略

Brinda Balasubramanian, Kiren Yacqub-Usman, Simran Venkatraman, Kyaw Zwar Myint, Jitlada Juengsamarn, Poowanai Sarkhampee, Nithi Lertsawatvicha, Jittiyawadee Sripa, Thiti Kuakpaetoon, Chinnawut Suriyonplengsaeng, Kanokpan Wongprasert, Anna M Grabowska, David O Bates, Tavan Janvilisri, Rutaiwan Tohto

In Silico Target Identification of Galangin, as an Herbal Flavonoid against Cholangiocarcinoma

通过计算机模拟靶标鉴定高良姜素,作为抗胆管癌的草药类黄酮

Brinda Balasubramanian, Simran Venkatraman, Kyaw Zwar Myint, Sucheewin Krobthong, Patompon Wongtrakoongate, Jittiyawadee Sripa, Panthip Rattanasinganchan, Pornphimon Metheenukul, Rutaiwan Tohtong

Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells

EGFR酪氨酸激酶抑制剂与细胞毒药物联合应用对胆管癌细胞的影响

Boonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, Kyaw Zwar Myint, Thannicha Sae-Lao, Pam Collier, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Brinda Balasubramanian, Simran Venkatraman, Isioma U Egbuniwe, Dhanwant Gomez, Abhik Mukherjee, Supeecha Kumkate, Tavan Janvilisri, Abed